Well boys, Add one more to the list. As an "older" physician (cardiologist) I have also been in since the beginning and basically never sold. I remain a believer. (or perchance a fool, time will tell). Also had Genzyme Tissue Reparir and the Genzyme oncology spin off. That was sure fun. GTCB is my largest holding and I have continued to add. Love the science and the company's ability to make vast quantities of therapeutic proteins. Was particulary struck by the ability to make human albumin in cows since this represented such a large market and dealt so well with the potential for contaminants (were prions the fear here?) anyway this went nowhere to my knowlege. I thought the use of ATIII in heparin resistance and potential to make TPA via transgenics would come to fruition. Now the The hope for an oral Rx for hemophelia, production of pure Mabs, coag factors, A1AT and more of course represent such basic needs in medicine that I remain astounded by the lack of recognition this company has received. I keep buying. I admire Dew's fine work in educating us all. I was always curious about the details of the work by Dr. Judah Volkman many years ago (or was it with Entremed?) that I think may have spurred the partnership with Genzyme and GTCB re AT III (not positive it was Dr. Volkman,) as an inhibitor of neovascularization in tumors. Anyone know what ever happened there? That news (a long time past) spurred the stock price tremendously. Best wishes to all. bp
